Clinical Trials in Imola, Italy
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Kidney Disease, Chronic
Boehringer Ingelheim11,000 enrolled399 locationsNCT06531824
Recruiting
Not Applicable
intErnet-based iNterventions FOR Cardiac arrEst suRvivors
Quality of LifeSexual DysfunctionDepression, Anxiety+3 more
Azienda Usl di Bologna137 enrolled2 locationsNCT06395558